While everyone's been chasing AI stocks and watching Nvidia hit new highs, a massive sector has been quietly getting demolished. Medical technology stocks—the companies that make surgical equipment, medical devices, and diagnostic tools—have crashed 25% to 50% over the past six months. The MedTech index is sitting at the same level it was six years ago.

Boston Scientific, Stryker, Abbott, Medtronic—these are huge, established companies with real revenue and real profits. And they're down by amounts that would normally trigger breathless CNBC coverage. But because they're not AI-related, nobody's talking about it.

So what's going on? Is this a buying opportunity or a value trap? Let me break down what I'm seeing.

First, the valuation reset. These stocks got expensive. Really expensive. During the post-COVID recovery, investors bid up anything healthcare-related, assuming demand would stay elevated forever. Elective surgeries came roaring back, hospitals were restocking equipment, and MedTech companies were trading at premium multiples. That party's over.

Second, regulatory uncertainty. The FDA has been tightening approval processes, particularly for cardiovascular devices and implantables. Longer approval times mean longer cash burn before products hit the market. That hits growth forecasts, and growth stocks hate uncertainty.

Third, China exposure. Many MedTech companies generate 15-25% of revenue from China, and that market has slowed dramatically. Chinese hospitals are under budget pressure, the government is pushing for domestic alternatives, and geopolitical tensions aren't helping. Nobody wants to talk about it publicly, but it's showing up in guidance cuts.

Fourth—and this is the big one—Medicare reimbursement rates. Hospitals are the customers here, and hospitals get paid by Medicare. When reimbursement rates get squeezed, hospitals delay equipment purchases. It's that simple. And with the federal budget under pressure, those reimbursement rates aren't going up anytime soon.

So is this a buying opportunity? But you need to be honest about what you're buying into.